![]() |
市场调查报告书
商品编码
1567798
到 2030 年北美医用超音波流量计市场预测 - 区域分析 - 按实施类型、技术、应用和最终用户North America Medical Ultrasound Flow Meter Market Forecast to 2030 - Regional Analysis - by Implementation Type, Technology, Application, and End User |
2022年北美医用超音波流量计市值为7,440万美元,预计到2030年将达到1.5277亿美元;预计2022年至2030年复合年增长率为9.4%。
心血管和呼吸系统疾病数量的增加推动了北美医疗超音波流量市场
全球每年有数百万人因心血管疾病 (CVD) 死亡。根据2022年心臟病和中风统计更新说明书《全球疾病负担》,2020年全球有1.191亿患者因CVD死亡。 68.2分别为 100 万。根据美国国家慢性病预防和健康促进中心心臟病和中风预防部门的数据,2022 年,美国约有 697,000 人患有心臟病。年,美国(占总人口的45.1%)可能会受到某种形式的心血管疾病的影响。 ) 手术。
慢性阻塞性肺病(COPD)会阻碍肺部气流,进而导致呼吸衰竭。它是危及生命的疾病之一,导致全世界数百万人死亡。据世界卫生组织(WHO)称,2022年,慢性阻塞性肺病是第三大死因。根据美国疾病管制与预防中心 (CDC) 的数据,2020 年,慢性阻塞性肺病 (COPD) 是美国第六大死因。因此,心血管疾病和呼吸系统疾病数量的增加促进了与超音波流量计结合的外部支援设备的越来越多的使用。例如,体外膜氧合(ECMO)是一种生命维持系统,透过医用管道向患者体内泵送液体提供临时解决方案,它与超音波流量计相结合,代替心臟或肺部工作,以确保准确的测量结果。
北美医用超音波流量计市场概况
北美医用超音波流量计市场分为美国、加拿大和墨西哥。心血管疾病和呼吸系统疾病盛行率的上升以及市场参与者不断发展的策略发展有助于该地区的市场发展。美国拥有领先的医用超音波流量计市场份额。
北美医用超音波流量计市场收入及 2030 年预测(百万美元)
北美医用超音波流量计市场细分
北美医用超音波流量计市场按实施、技术、应用、最终用户和国家/地区进行分类。
依实施情况,北美医用超音波流量计市场分为外夹式、内联式等。 2022 年,外夹式细分市场占据最大的市场份额。
从技术面来看,北美医用超音波流量计市场分为多普勒流量计、时差流量计和混合流量计。 2022 年,多普勒细分市场占据最大的市场份额。
依应用划分,北美医用超音波流量计市场分为心肺机、体外膜氧合、灌注、器官运输系统等。 2022 年,其他细分市场占据最大市场份额。
依最终用户划分,北美医用超音波流量计市场分为医院和诊所、门诊手术中心、研究实验室等。 2022 年,医院和诊所细分市场占据最大市场份额。
依国家/地区划分,北美医用超音波流量计市场分为美国、加拿大和墨西哥。 2022年,美国主导北美医用超音波流量计市场份额。
Arjo AB、PSG Dover、Moor Instruments Ltd、Transonic Systems Inc、Compumedics Ltd、Cook Medical Holdings LLC、GF Health Products Inc、Sonotec GmbH、StrainMeasurement Devices Inc、Siemens AG、Perimed AB 和 Sensirion Holding AG 是一些领先的公司公司在北美医疗超音波流量计市场运作。
The North America medical ultrasound flow meter market was valued at US$ 74.40 million in 2022 and is projected to reach US$ 152.77 million by 2030; it is estimated to record a CAGR of 9.4% from 2022 to 2030.
Rising Number of Cardiovascular and Respiratory Diseases Fuels North America Medical Ultrasound Flow Market
Millions of deaths are recorded due to cardiovascular diseases (CVDs) annually across the world. According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, Global Burden of Disease, 119.1 million patients succumbed to death globally due to CVD in 2020. It also stated that the global prevalence of stroke and ischemic stroke in 2020 was 89.1 million and 68.2 million, respectively. As per the National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, ~697,000 people were reported to have had heart disease in the US in 2022. According to the American Heart Association, over 130 million people in the US (45.1% of the total population) are likely to be affected by some form of cardiovascular disease by 2035. Further, according to the National Library of Medicine, about 400,000 coronary artery bypass grafting (CABG) surgeries were performed in 2022.
Chronic obstructive pulmonary disease (COPD) obstructs the airflow from the lungs, which can lead to respiratory failure. It is one of the life-threatening illnesses that cause millions of deaths across the world. According to the World Health Organization (WHO), COPD was the third leading cause of death in 2022. In 2020, about 90% of COPD deaths occurred in low- and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), in 2020, COPD was the sixth leading cause of death in the US. Thus, the increasing number of CVDs and respiratory diseases has promoted the growing use of external support devices incorporated with ultrasound flow meters. For instance, extracorporeal membrane oxygenation (ECMO)-a life support system that provides a temporary solution for pumping fluids in the patient's body through medical tubing-is incorporated with ultrasound flow meters to work in place of heart or lungs in order to ensure the accurate flow of oxygenated blood during surgical procedures.
North America Medical Ultrasound Flow Meter Market Overview
The North America medical ultrasound flow meter market is segmented into the US, Canada, and Mexico. The rising prevalence of cardiovascular diseases and respiratory diseases and growing strategic developments by market players contribute to the market development in the region. The US holds the leading medical ultrasound flow meter market share.
North America Medical Ultrasound Flow Meter Market Revenue and Forecast to 2030 (US$ Million)
North America Medical Ultrasound Flow Meter Market Segmentation
The North America medical ultrasound flow meter market is categorized into implementation, technology, application, end user, and country.
Based on implementation, the North America medical ultrasound flow meter market is segmented into clamp-on, inline, and others. The clamp-on segment held the largest market share in 2022.
In terms of technology, the North America medical ultrasound flow meter market is categorized into doppler, transit-time, and hybrid. The doppler segment held the largest market share in 2022.
By application, the North America medical ultrasound flow meter market is segmented into heart and lung machines, extracorporeal membrane oxygenation, perfusion, organs transportation system, and others. The others segment held the largest market share in 2022.
By end user, the North America medical ultrasound flow meter market is bifurcated into hospitals and clinics, ambulatory surgical centers, research laboratories, and others. The hospitals and clinics segment held the largest market share in 2022.
By country, the North America medical ultrasound flow meter market is segmented into the US, Canada, and Mexico. The US dominated the North America medical ultrasound flow meter market share in 2022.
Arjo AB, PSG Dover, Moor Instruments Ltd, Transonic Systems Inc, Compumedics Ltd, Cook Medical Holdings LLC, GF Health Products Inc, Sonotec GmbH, Strain Measurement Devices Inc, Siemens AG, Perimed AB, and Sensirion Holding AG are some of the leading companies operating in the North America medical ultrasound flow meter market.